VT

Venkat R. Thalladi

TI Theravance Biopharma R&D Ip: 5 patents #3 of 70Top 5%
📍 Foster City, CA: #36 of 545 inventorsTop 7%
🗺 California: #4,226 of 67,585 inventorsTop 7%
Overall (2023): #25,752 of 537,848Top 5%
5
Patents 2023

Issued Patents 2023

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11795180 Formulation of a pan-JAK inhibitor Bernardus Joseph Nitert, Yvonne Rosiaux, Marian E. Van Der Veen, Nathan Schulpen, Jens Maes +2 more 2023-10-24
11780852 Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Ryan Hudson, Jennifer Kozak, Dante D. Podesto, Xiaojun Huang 2023-10-10
11718591 Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof Adam D. Hughes, Melissa Fleury, Miroslav Rapta, Gene Timothy Fass, Michael Simeone +2 more 2023-08-08
11718616 JAK kinase inhibitor compounds for treatment of respiratory disease Paul R. Fatheree, John R. Jacobsen, Anne-Marie Beausoleil, Gary E. L. Brandt, Melissa Fleury +9 more 2023-08-08
11642332 (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta 2023-05-09